Benlysta 200 mg solution for injection in pre-filled pen.
219240
Approved small_molecule active
Quick answer
Benlysta 200 mg solution for injection in pre-filled pen. for Systemic Lupus Erythematosus is a Approved program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline Biologicals S.A.
- Indication
- Systemic Lupus Erythematosus
- Phase
- Approved
- Modality
- small_molecule
- Status
- active